vs
Side-by-side financial comparison of First Foundation Inc. (FFWM) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
First Foundation Inc. is the larger business by last-quarter revenue ($48.4M vs $47.7M, roughly 1.0× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -97.9%, a 93.1% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-35.2M). Over the past eight quarters, First Foundation Inc.'s revenue compounded faster (-2.7% CAGR vs -20.2%).
John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
FFWM vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $48.4M | $47.7M |
| Net Profit | $-8.0M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | -97.5% | 14.3% |
| Net Margin | -97.9% | -4.8% |
| Revenue YoY | 421.7% | -47.3% |
| Net Profit YoY | 43.0% | -200.9% |
| EPS (diluted) | $-0.09 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $48.4M | $47.7M | ||
| Q3 25 | $63.6M | $122.1M | ||
| Q2 25 | $51.4M | $85.2M | ||
| Q1 25 | $71.4M | $41.1M | ||
| Q4 24 | $9.3M | $90.5M | ||
| Q3 24 | $9.2M | $91.6M | ||
| Q2 24 | $57.5M | $94.4M | ||
| Q1 24 | $51.1M | $74.9M |
| Q4 25 | $-8.0M | $-2.3M | ||
| Q3 25 | $-146.3M | $40.1M | ||
| Q2 25 | $-7.7M | $23.6M | ||
| Q1 25 | $6.9M | $-37.4M | ||
| Q4 24 | $-14.1M | $2.3M | ||
| Q3 24 | $-82.2M | $3.6M | ||
| Q2 24 | $3.1M | $-860.0K | ||
| Q1 24 | $793.0K | $-4.2M |
| Q4 25 | -97.5% | 14.3% | ||
| Q3 25 | -92.7% | 61.8% | ||
| Q2 25 | -21.1% | 53.2% | ||
| Q1 25 | 8.8% | -70.7% | ||
| Q4 24 | -247.7% | 34.8% | ||
| Q3 24 | -1276.7% | 28.0% | ||
| Q2 24 | 4.6% | 26.5% | ||
| Q1 24 | -0.2% | 14.7% |
| Q4 25 | -97.9% | -4.8% | ||
| Q3 25 | -230.1% | 32.8% | ||
| Q2 25 | -15.0% | 27.7% | ||
| Q1 25 | 9.7% | -90.9% | ||
| Q4 24 | -152.2% | 2.5% | ||
| Q3 24 | -896.9% | 4.0% | ||
| Q2 24 | 5.4% | -0.9% | ||
| Q1 24 | 1.6% | -5.6% |
| Q4 25 | $-0.09 | $0.01 | ||
| Q3 25 | $-1.78 | $0.23 | ||
| Q2 25 | $-0.09 | $0.14 | ||
| Q1 25 | $0.08 | $-0.23 | ||
| Q4 24 | $-0.24 | $0.03 | ||
| Q3 24 | $-1.23 | $0.02 | ||
| Q2 24 | $0.05 | $-0.01 | ||
| Q1 24 | $0.01 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.6B | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $912.6M | $-261.8M |
| Total Assets | $11.9B | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.6B | $215.5M | ||
| Q3 25 | $1.7B | $140.4M | ||
| Q2 25 | $1.1B | $92.9M | ||
| Q1 25 | $1.0B | $108.5M | ||
| Q4 24 | $1.0B | $88.6M | ||
| Q3 24 | $1.1B | $88.2M | ||
| Q2 24 | $1.4B | $105.5M | ||
| Q1 24 | $1.6B | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $912.6M | $-261.8M | ||
| Q3 25 | $917.9M | $-264.2M | ||
| Q2 25 | $1.1B | $-308.2M | ||
| Q1 25 | $1.1B | $-334.1M | ||
| Q4 24 | $1.1B | $-301.3M | ||
| Q3 24 | $1.1B | $-311.3M | ||
| Q2 24 | $933.2M | $-321.7M | ||
| Q1 24 | $928.7M | $-330.5M |
| Q4 25 | $11.9B | $396.9M | ||
| Q3 25 | $11.9B | $396.1M | ||
| Q2 25 | $11.6B | $342.9M | ||
| Q1 25 | $12.6B | $327.2M | ||
| Q4 24 | $12.6B | $350.9M | ||
| Q3 24 | $13.4B | $389.5M | ||
| Q2 24 | $13.7B | $395.6M | ||
| Q1 24 | $13.6B | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-31.9M | $74.6M |
| Free Cash FlowOCF − Capex | $-35.2M | $74.6M |
| FCF MarginFCF / Revenue | -72.8% | 156.3% |
| Capex IntensityCapex / Revenue | 6.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.9M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-31.9M | $74.6M | ||
| Q3 25 | $9.2M | $47.6M | ||
| Q2 25 | $-16.3M | $-15.1M | ||
| Q1 25 | $-552.0K | $20.0M | ||
| Q4 24 | $-8.7M | $15.2M | ||
| Q3 24 | $14.2M | $9.9M | ||
| Q2 24 | $-9.1M | $33.5M | ||
| Q1 24 | $7.2M | $45.0M |
| Q4 25 | $-35.2M | $74.6M | ||
| Q3 25 | $8.6M | $47.6M | ||
| Q2 25 | $-16.7M | $-15.1M | ||
| Q1 25 | $-2.5M | $19.9M | ||
| Q4 24 | $-11.4M | — | ||
| Q3 24 | $13.4M | $9.9M | ||
| Q2 24 | $-9.4M | $33.4M | ||
| Q1 24 | $5.9M | $44.9M |
| Q4 25 | -72.8% | 156.3% | ||
| Q3 25 | 13.5% | 39.0% | ||
| Q2 25 | -32.4% | -17.7% | ||
| Q1 25 | -3.5% | 48.4% | ||
| Q4 24 | -123.5% | — | ||
| Q3 24 | 146.2% | 10.8% | ||
| Q2 24 | -16.3% | 35.4% | ||
| Q1 24 | 11.6% | 60.0% |
| Q4 25 | 6.9% | 0.0% | ||
| Q3 25 | 1.0% | 0.0% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | 2.8% | 0.1% | ||
| Q4 24 | 29.4% | 0.0% | ||
| Q3 24 | 9.0% | 0.0% | ||
| Q2 24 | 0.4% | 0.1% | ||
| Q1 24 | 2.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | -0.08× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | -2.96× | — | ||
| Q1 24 | 9.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
